More Than Just p-Values: MCID for the VAS, MSQ and FEMD in Patients With Primary Dysmenorrhea

Launched by ARTVIN CORUH UNIVERSITY · Feb 13, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how much improvement in pain and symptoms is meaningful for women who experience primary dysmenorrhea, which is severe menstrual pain. The researchers want to find out the smallest change in pain levels that patients notice as being helpful. They will use different tools, like a scale to measure pain and questionnaires about menstrual symptoms and emotional well-being, to gather this information.

To be part of this study, participants need to be women aged 18 to 35 who regularly experience moderate to severe menstrual pain. They should not have had any serious gynecological issues or other conditions that could affect their menstrual cycle. If eligible, participants can expect to answer questions about their pain and symptoms during their menstrual cycle. The study is currently recruiting participants, so it's a great opportunity for those who qualify to contribute to important research that could help improve understanding and treatment of menstrual discomfort.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of PD according to the "No. 345-Primary Dysmenorrhea Consensus Guideline",
• • Pain level of three or more according to VAS during activity (moderate to severe pain),
• • Patients aged 18-35 years (when PD becomes more prevalent),
• • Regular menstrual cycle with a duration of 28±7 days,
• • Nulliparity.
• Exclusion Criteria:
• • Historical background of chronic urogenital infections or drug use,
• • Pregnancy,
• • Secondary dysmenorrhoea caused by gynaecological conditions such as endometriosis, adenomyosis and uterine fibroids.